×
Rheumatology222
Our Other TA
Our Other TA
test20240104
EyeCare222
Hepatology
Oncology
Dermatology
Rheumatology
Neuroscience
Gastroenterology
EyeCare
Report and Adverse Event
Login
Register
{%buzitemName%}
{%buzbrandMenuItems%}
{%bitemName%}
{%barrowSpan%}
{%bsubBrandMenuItems%}
{%sbitemName%}
{%sbarrowSpan%}
{%sbproductMenuItems%}
{%pitemKeyName%} {%pitemBadges%}
{%parrowSpan%}
{%pselfProduct%}
{%mNavitemName%}
{%lSlanguageSelectorLabel%}
{%lSactiveLanguage%}
{%lScountries%}
{%allMenuItem%}
{%cScountryInfo%}
{%cSlanguages%}
This website is for Taiwan Healthcare Professionals only
Home
Video
Congress
E-newsletter
PsA: UPA & RZB three-year follow up data
ACR 2024 Congress Highlight
UPJOINT: UPA 在 PsA 的真實世界研究
Upadacitinib 於 AS 及 nr-axSpA 最新資訊
Upadacitinib 於中重度類風濕性關節炎 (RA) 的真實世界療效
Upadacitinib 治療RA 的六個月期中真實世界療效分析結果
Upadacitinib 對於僵直性脊椎炎(AS)病人的療效持續性
以UPA治療高心血管風險類風濕性關節炎族群的安全性
Upadacitinib於乾癬性關節炎的最新資訊
Upadacitinib 治療精選
UPA跨適應症安全性解析
Pipeline
Contact Us
Previous
Next
11111
Matches for {{key}}
{{result.pageTitle}}
{{result.specialization}}
Matches for {{key}}
{{result.pageTitle}}
{{result.specialization}}
No result found for {{key}}